Agrivida Launches $20 Million Financing Round with Lead Investment from the Open Prairie Rural Opportunities Fund
Summary
The new funding will facilitate expansion of the Agrivida research and development platform and advancement of the companys commercialization strategy for its GRAINZYME® Phytase technology into the global poultry and swine markets. Agrivida, headquartered in Village of Four Seasons, Missouri, is an animal health and nutrition company that focuses on development of feed additives for poultry, swine, dairy and beef cattle and aquaculture. "Agrividas sustainability focus on animal feed has unlocked the power of the corn kernel to enhance the production and delivery of beneficial enzymes and other nutrients while improving the environment by reducing levels of nitrogen and phosphorus," said Open Prairies founder and managing partner, Jim Schultz. "Agrivida has achieved a number of milestones including commercial revenue growth in poultry, approval from the Food and Drug Administration Center for Veterinary Medicine on July 8, 2019 for sale of GRAINZYME® Phytase into US Swine, early stage research and development success for solutions in Animal Health and Ruminant additives and forages. Through its expertise across all functional business disciplines and an extensive network of professionals, Open Prairie works in partnership with its portfolio companies to accelerate growth while providing top-tier returns to its investors.